Arcus Biosciences

IPO

Arcus Biosciences is a biotech company in Hayward, United States, founded in 2015. It has raised $544.0M across 4 rounds, most recently a $320.0M Corporate Round in 2024 (est.).

Pursuit of Cures for Cancer

Employees
201–500
Founded
2015
Business Model
B2B
Total Funding
$544.0M
Last Round
$320.0M Corporate RoundJan 2024
Rounds
4
Type
Public

Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.

Indexed holds 4 funding rounds and 4 investors for this company. The full record is or through the API.

About

Founded in 2015, Arcus Biosciences is a highly productive, clinical-stage, global biopharmaceutical company with the goal of developing best-in-class molecules and combination therapies for people with cancer. Its team of scientists, physicians, advisors, and other leaders targets well-understood biological pathways where there is an opportunity to develop medicines with improved safety and efficacy. Arcus has advanced molecules from program initiation to IND filing in as short as 18 months, and moves from proof-of-concept Phase 1 to randomized Phase 2 and registrational Phase 3 studies in just a few years, guided by its vision of "Combining to Cure."

Summary

It lists 201–500 employees. It has raised $544.0M in total across 4 rounds, most recently a $320.0M Corporate Round in 2024 (est.). Investors include Gilead Sciences, Taiho Ventures and GV.

Tech & App Stack

4 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding History

Data from Indexed.vcUpdated
Corporate RoundCorporate Round2024 (est.)
$320.0M

Sign up to see all 4 events

Funding: Series A through Corporate Round. Amounts, valuations, and investors where available.

Investors

Similar Companies

BeiGeneIPO

BeOne Medicines develops transformative oncology medicines through rigorous science, an accelerat...

Cambridge, United States10001+Biotech, Oncology
Corporate RoundTotal funding$2.8BJan 2020
Tiantan Biological / China Biologic (泰邦生物集团)

China's leading blood products manufacturer

Beijing, China1001–5000Biotech, Healthcare
Growth EquityTotal funding$5.1BAug 2022
Pharmaceutical Product Development, Inc. (PPD)Acquired

Global contract research organization providing comprehensive drug development and laboratory ser...

Wilmington, United States10001+Biotech, Healthcare
Private EquityTotal funding$3.9BJan 2019
Warner ChilcottAcquired

Specialty pharmaceutical company

Rockaway, United States1001–5000Biotech, Healthcare
Private EquityTotal funding$3.0BJan 2004
Altos Labs

Altos Labs combines academic science and industry development to create medicines that restore ce...

San Francisco, United States501–1000Life Sciences, Biotech
Series ATotal funding$3.0BJan 2022
Syneos HealthAcquired

Integrated biopharmaceutical solutions company

Burlington, United States10001+Biotech, Healthcare
Private EquityTotal funding$3.0BMay 2017

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

Arcus Biosciences on Indexed.vc
<a href="https://indexed.vc/companies/arcus-biosciences"><img src="https://indexed.vc/api/badge/company/arcus-biosciences" alt="Arcus Biosciences on Indexed.vc" width="260" height="76" /></a>